1. Home
  2. HUMA vs RWAY Comparison

HUMA vs RWAY Comparison

Compare HUMA & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.72

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Logo Runway Growth Finance Corp.

RWAY

Runway Growth Finance Corp.

HOLD

Current Price

$6.82

Market Cap

226.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
RWAY
Founded
2004
2015
Country
United States
United States
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
226.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUMA
RWAY
Price
$0.72
$6.82
Analyst Decision
Strong Buy
Buy
Analyst Count
8
6
Target Price
$6.19
$9.50
AVG Volume (30 Days)
5.0M
513.1K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
21.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$444.16
$1.26
Revenue Next Year
$248.39
$1.25
P/E Ratio
N/A
$5.70
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$5.19
52 Week High
$2.55
$11.14

Technical Indicators

Market Signals
Indicator
HUMA
RWAY
Relative Strength Index (RSI) 48.35 62.22
Support Level $0.63 $5.25
Resistance Level $0.87 $6.97
Average True Range (ATR) 0.05 0.14
MACD 0.02 0.06
Stochastic Oscillator 81.13 90.65

Price Performance

Historical Comparison
HUMA
RWAY

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.

Share on Social Networks: